TY - JOUR
T1 - Development and validation of a clinical prediction rule for the development of diabetic foot ulceration
T2 - an analysis of data from five cohort studies
AU - Chappell, Francesca
AU - Crawford, Fay
AU - Horne, Margaret
AU - Leese, Graham
AU - Martin, Angela
AU - Weller, David
AU - Boulton, Andrew
AU - Abbott, Caroline
AU - Monteiro-Soares, Matilde
AU - Veves, Aristidis
AU - Riley, Richard
N1 - This independent research was funded by the UK National Institute for Health Research (NIHR) under its programme grants for health technology assessment scheme (15/171/01).
PY - 2021/5/25
Y1 - 2021/5/25
N2 - Introduction The aim of the study was to develop and validate a clinical prediction rule (CPR) for foot ulceration in people with diabetes.Research design and methods
Development of a CPR using individual participant data from four
international cohort studies identified by systematic review, with
validation in a fifth study. Development cohorts were from primary and
secondary care foot clinics in Europe and the USA (n=8255, adults over
18 years old, with diabetes, ulcer free at recruitment). Using data from
monofilament testing, presence/absence of pulses, and participant
history of previous ulcer and/or amputation, we developed a simple CPR
to predict who will develop a foot ulcer within 2 years of initial
assessment and validated it in a fifth study (n=3324). The CPR’s
performance was assessed with C-statistics, calibration slopes,
calibration-in-the-large, and a net benefit analysis.Results
CPR scores of 0, 1, 2, 3, and 4 had a risk of ulcer within 2 years of
2.4% (95% CI 1.5% to 3.9%), 6.0% (95% CI 3.5% to 9.5%), 14.0% (95% CI
8.5% to 21.3%), 29.2% (95% CI 19.2% to 41.0%), and 51.1% (95% CI 37.9%
to 64.1%), respectively. In the validation dataset,
calibration-in-the-large was −0.374 (95% CI −0.561 to −0.187) and
calibration slope 1.139 (95% CI 0.994 to 1.283). The C-statistic was
0.829 (95% CI 0.790 to 0.868). The net benefit analysis suggested that
people with a CPR score of 1 or more (risk of ulceration 6.0% or more)
should be referred for treatment.Conclusion
The clinical prediction rule is simple, using routinely obtained data,
and could help prevent foot ulcers by redirecting care to patients with
scores of 1 or above. It has been validated in a community setting, and
requires further validation in secondary care settings.
AB - Introduction The aim of the study was to develop and validate a clinical prediction rule (CPR) for foot ulceration in people with diabetes.Research design and methods
Development of a CPR using individual participant data from four
international cohort studies identified by systematic review, with
validation in a fifth study. Development cohorts were from primary and
secondary care foot clinics in Europe and the USA (n=8255, adults over
18 years old, with diabetes, ulcer free at recruitment). Using data from
monofilament testing, presence/absence of pulses, and participant
history of previous ulcer and/or amputation, we developed a simple CPR
to predict who will develop a foot ulcer within 2 years of initial
assessment and validated it in a fifth study (n=3324). The CPR’s
performance was assessed with C-statistics, calibration slopes,
calibration-in-the-large, and a net benefit analysis.Results
CPR scores of 0, 1, 2, 3, and 4 had a risk of ulcer within 2 years of
2.4% (95% CI 1.5% to 3.9%), 6.0% (95% CI 3.5% to 9.5%), 14.0% (95% CI
8.5% to 21.3%), 29.2% (95% CI 19.2% to 41.0%), and 51.1% (95% CI 37.9%
to 64.1%), respectively. In the validation dataset,
calibration-in-the-large was −0.374 (95% CI −0.561 to −0.187) and
calibration slope 1.139 (95% CI 0.994 to 1.283). The C-statistic was
0.829 (95% CI 0.790 to 0.868). The net benefit analysis suggested that
people with a CPR score of 1 or more (risk of ulceration 6.0% or more)
should be referred for treatment.Conclusion
The clinical prediction rule is simple, using routinely obtained data,
and could help prevent foot ulcers by redirecting care to patients with
scores of 1 or above. It has been validated in a community setting, and
requires further validation in secondary care settings.
UR - https://drc.bmj.com/content/9/1/e002150#supplementary-materials
U2 - 10.1136/bmjdrc-2021-002150
DO - 10.1136/bmjdrc-2021-002150
M3 - Article
SN - 2052-4897
VL - 9
JO - BMJ Open Diabetes Research and Care
JF - BMJ Open Diabetes Research and Care
IS - 1
M1 - e002150
ER -